Analysts' Actions: CREE DIS MDRX TWX WLP

TheStreet.com

NEW YORK (TheStreet) -- CHANGE IN RATINGS

Cigna was downgraded at Jefferies to hold from buy. Valuation call, as the stock is up 70% since July, Jefferies said. $75 price target.

Cree was downgraded at Sterne Agee to neutral. $59 price target. Estimates also cut, following negative checks in the lighting business, Sterne Agee said.

Disney was initiated with an outperform rating at BMO Capital. $76 price target. Company deserves a premium valuation, BMO Capital said.

Fusion-io was upgraded at UBS to buy from neutral. The stock price decline and strong flash demand overcompensate for the near-term risks, UBS said. Price target goes to $19.


Blackhawk was initiated with a buy rating at Goldman Sachs. $28 price target. Company should see improved store productivity and growth through new products, Goldman said.

Allscripts Healthcare Solutions was upgraded at Citigroup to buy from neutral. Next-generation solutions will capitalize on the population health opportunity, said Citigroup. Price target goes to $18.

Monster Beverage was initiated with an overweight rating at Morgan Stanley. $65 price target. Valuation does not fully reflect strong growth potential, Morgan Stanley said.


Melco Crown was downgraded at UBS to neutral from buy. Operations and liquidity have improved recently, with these events now priced in, UBS said. Price target goes to $26.

Solarcity was downgraded at Credit Suisse to neutral from outperform. Valuation call, based on a $28 price target, Credit Suisse said.

Time Warner was initiated with a market-perform rating at BMO Capital. Valuation call, based on a $64 price target, BMO Capital said.

Vivus was downgraded at Lazard Capital Markets to neutral from buy. The window of opportunity is closing for Qsymia in the obesity market, Lazard Capital Markets said.


Wellpoint was upgraded at Jefferies to buy from hold. $92 price target. Buybacks will help boost growth, Jefferies said.

STOCK COMMENTS/EPS CHANGES

Mosaic price target and estimates were updated at UBS. Estimates were adjusted after announcing plans to repurchase shares and raise its dividend, UBS said. Price target was raised to $68.

SodaStream price target was increased at Citigroup to $66. Strong top- and bottom-line outlook into 2016, Citi said.

Teekay LNG price target was increased at UBS to $43. Reflects future cash flows and a roll forward of the DDM derived model, said UBS.

Visa price target was raised at Deutsche Bank to $196. More positive on the growth outlook, following marketing meetings with management, Deutsche Bank said. Buy rating.

Yahoo! target was boosted at Cantor Fitzgerald. Shares are now seen reaching $30. Alibaba continues to see higher sales growth and expanding margins. Buy rating.

>To submit a news tip, email: tips@thestreet.com.

Follow TheStreet on Twitter and become a fan on Facebook.

EXCLUSIVE OFFER: See inside Jim Cramer’s multi-million dollar charitable trust portfolio to see the stocks he thinks could be potentially HUGE winners. Click here to see his holdings for FREE.

Rates

View Comments (0)